COVID-19 Variants, Available Treatments, and Vaccinations: An Overview Study

SARS-CoV-2 is the recent variation of the corona virus which is infecting people around the world and has affected more than 258 million people worldwide. Upon observation, the virus is similar to the coronavirus which spread from the horseshoe bat or wild animals to human beings. Up to date, there...

Full description

Bibliographic Details
Published in:Al-Rafidain Journal of Medical Sciences
Main Author: Mohammed A.H.; Suhaimi A.M.; Hassan B.A.R.
Format: Review
Language:English
Published: Al-Rafidain University College 2021
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85163767814&doi=10.54133%2fajms.v1i.42&partnerID=40&md5=28fd5156d4f718f134e78461fd7f0659
id 2-s2.0-85163767814
spelling 2-s2.0-85163767814
Mohammed A.H.; Suhaimi A.M.; Hassan B.A.R.
COVID-19 Variants, Available Treatments, and Vaccinations: An Overview Study
2021
Al-Rafidain Journal of Medical Sciences
1

10.54133/ajms.v1i.42
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85163767814&doi=10.54133%2fajms.v1i.42&partnerID=40&md5=28fd5156d4f718f134e78461fd7f0659
SARS-CoV-2 is the recent variation of the corona virus which is infecting people around the world and has affected more than 258 million people worldwide. Upon observation, the virus is similar to the coronavirus which spread from the horseshoe bat or wild animals to human beings. Up to date, there have been three major variants of the coronavirus which have been identified in UK, South Africa, and India which are spreading to other countries. Based on the current data, it is suggested that the incidents of repeated infection with SARS-CoV-2 is related to the level of neutralizing antibodies and the retained memory response which follows infection. Moreover, recently, a critical issue arises in relation to the association of black fungus and COVID-19, and urgent investigation is required. As a treatment method of COVID-19, FDA has recently approved the feasibility of Remdesivir to treat COVID-19 as emergency use authorization (EUA). There are also various possible antivirals which are still undergoing clinical trial. After widespread of the vaccine, the results showed that EUA vaccines have been effective in controlling COVID-19 in patients. However, these licensed vaccines ought to be reviewed to ensure they are also effective in combating the rising variants of SARS-CoV-2. © 2021 The Author(s). Published by Al-Rafidain University College.
Al-Rafidain University College
27893219
English
Review
All Open Access; Hybrid Gold Open Access
author Mohammed A.H.; Suhaimi A.M.; Hassan B.A.R.
spellingShingle Mohammed A.H.; Suhaimi A.M.; Hassan B.A.R.
COVID-19 Variants, Available Treatments, and Vaccinations: An Overview Study
author_facet Mohammed A.H.; Suhaimi A.M.; Hassan B.A.R.
author_sort Mohammed A.H.; Suhaimi A.M.; Hassan B.A.R.
title COVID-19 Variants, Available Treatments, and Vaccinations: An Overview Study
title_short COVID-19 Variants, Available Treatments, and Vaccinations: An Overview Study
title_full COVID-19 Variants, Available Treatments, and Vaccinations: An Overview Study
title_fullStr COVID-19 Variants, Available Treatments, and Vaccinations: An Overview Study
title_full_unstemmed COVID-19 Variants, Available Treatments, and Vaccinations: An Overview Study
title_sort COVID-19 Variants, Available Treatments, and Vaccinations: An Overview Study
publishDate 2021
container_title Al-Rafidain Journal of Medical Sciences
container_volume 1
container_issue
doi_str_mv 10.54133/ajms.v1i.42
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85163767814&doi=10.54133%2fajms.v1i.42&partnerID=40&md5=28fd5156d4f718f134e78461fd7f0659
description SARS-CoV-2 is the recent variation of the corona virus which is infecting people around the world and has affected more than 258 million people worldwide. Upon observation, the virus is similar to the coronavirus which spread from the horseshoe bat or wild animals to human beings. Up to date, there have been three major variants of the coronavirus which have been identified in UK, South Africa, and India which are spreading to other countries. Based on the current data, it is suggested that the incidents of repeated infection with SARS-CoV-2 is related to the level of neutralizing antibodies and the retained memory response which follows infection. Moreover, recently, a critical issue arises in relation to the association of black fungus and COVID-19, and urgent investigation is required. As a treatment method of COVID-19, FDA has recently approved the feasibility of Remdesivir to treat COVID-19 as emergency use authorization (EUA). There are also various possible antivirals which are still undergoing clinical trial. After widespread of the vaccine, the results showed that EUA vaccines have been effective in controlling COVID-19 in patients. However, these licensed vaccines ought to be reviewed to ensure they are also effective in combating the rising variants of SARS-CoV-2. © 2021 The Author(s). Published by Al-Rafidain University College.
publisher Al-Rafidain University College
issn 27893219
language English
format Review
accesstype All Open Access; Hybrid Gold Open Access
record_format scopus
collection Scopus
_version_ 1809678481289641984